Supplementary Data from PP2Ac Deficiency Enhances Tumor Immunogenicity by Activating STING–Type I Interferon Signaling in Glioblastoma

Supplementary Data from PP2Ac Deficiency Enhances Tumor Immunogenicity by Activating STING–Type I Interferon Signaling in Glioblastoma

<p>Cluster defining genes from scRNAseq data</p>

Saved in:

Bibliographic Details
Main Author:	Isha Mondal (16721699) (author)
Other Authors:	Oishika Das (16721702) (author), Raymond Sun (16721705) (author), Jian Gao (16721708) (author), Bohyeon Yu (16721711) (author), Aaron Diaz (16721714) (author), Jinan Behnan (16721717) (author), Abhishek Dubey (16721720) (author), Zhipeng Meng (16721723) (author), Emad Eskandar (16721726) (author), Beisi Xu (14941098) (author), Rongze Olivia Lu (16721729) (author), Winson S. Ho (16721732) (author)
Published:	2025
Subjects:	Cancer Tumor Biology Immuno-oncology CNS Cancers Gliomas, Glioblastomas Immunology Immune responses to cancer Immunotherapy Combination immunotherapy Tumor Microenvironment Immune cells and the microenvironment
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Supplementary Table S1 from Glioblastoma Vascular Plasticity Limits Effector T-cell Infiltration and Is Blocked by cAMP Activation
by: Zixi Qin (17091455)
Published: (2025)

Supplementary Table S2 from Glioblastoma Vascular Plasticity Limits Effector T-cell Infiltration and Is Blocked by cAMP Activation
by: Zixi Qin (17091455)
Published: (2025)

Figure 1 from Inhibition of Extracellular Matrix Protein Fibulin-3 Reduces Immunosuppressive Signaling and Increases Macrophage Activation in Glioblastoma
by: Somanath Kundu (22229763)
Published: (2025)

Figure 2 from Inhibition of Extracellular Matrix Protein Fibulin-3 Reduces Immunosuppressive Signaling and Increases Macrophage Activation in Glioblastoma
by: Somanath Kundu (22229763)
Published: (2025)

Figure 3 from Inhibition of Extracellular Matrix Protein Fibulin-3 Reduces Immunosuppressive Signaling and Increases Macrophage Activation in Glioblastoma
by: Somanath Kundu (22229763)
Published: (2025)

Figure 4 from Inhibition of Extracellular Matrix Protein Fibulin-3 Reduces Immunosuppressive Signaling and Increases Macrophage Activation in Glioblastoma
by: Somanath Kundu (22229763)
Published: (2025)

Figure 5 from Inhibition of Extracellular Matrix Protein Fibulin-3 Reduces Immunosuppressive Signaling and Increases Macrophage Activation in Glioblastoma
by: Somanath Kundu (22229763)
Published: (2025)

Figure 6 from Inhibition of Extracellular Matrix Protein Fibulin-3 Reduces Immunosuppressive Signaling and Increases Macrophage Activation in Glioblastoma
by: Somanath Kundu (22229763)
Published: (2025)

Supplementary video from Phagocytosis of Glioma Cells Enhances the Immunosuppressive Phenotype of Bone Marrow–Derived Macrophages
by: Min Wu (14962986)
Published: (2025)

Table S1 from Phagocytosis of Glioma Cells Enhances the Immunosuppressive Phenotype of Bone Marrow–Derived Macrophages
by: Min Wu (14962986)
Published: (2025)

Table S2 from Phagocytosis of Glioma Cells Enhances the Immunosuppressive Phenotype of Bone Marrow–Derived Macrophages
by: Min Wu (14962986)
Published: (2025)

Table S3 from Phagocytosis of Glioma Cells Enhances the Immunosuppressive Phenotype of Bone Marrow–Derived Macrophages
by: Min Wu (14962986)
Published: (2025)

Figure S1 from T-cell Receptor Therapy Targeting Mutant Capicua Transcriptional Repressor in Experimental Gliomas
by: Michael Kilian (16697663)
Published: (2025)

Figure S2 from T-cell Receptor Therapy Targeting Mutant Capicua Transcriptional Repressor in Experimental Gliomas
by: Michael Kilian (16697663)
Published: (2025)

Figure S3 from T-cell Receptor Therapy Targeting Mutant Capicua Transcriptional Repressor in Experimental Gliomas
by: Michael Kilian (16697663)
Published: (2025)

Supplementary Figure 1 from Tunneling CARs: Increasing CAR T-Cell Tumor Infiltration through the Overexpression of MMP-7 and Osteopontin-b
by: Stacey Van Pelt (15129557)
Published: (2025)

Supplementary Figure 2 from Tunneling CARs: Increasing CAR T-Cell Tumor Infiltration through the Overexpression of MMP-7 and Osteopontin-b
by: Stacey Van Pelt (15129557)
Published: (2025)

Supplementary Figure 3 from Tunneling CARs: Increasing CAR T-Cell Tumor Infiltration through the Overexpression of MMP-7 and Osteopontin-b
by: Stacey Van Pelt (15129557)
Published: (2025)

Supplementary Figure 4 from Tunneling CARs: Increasing CAR T-Cell Tumor Infiltration through the Overexpression of MMP-7 and Osteopontin-b
by: Stacey Van Pelt (15129557)
Published: (2025)

Supplementary Figure 5 from Tunneling CARs: Increasing CAR T-Cell Tumor Infiltration through the Overexpression of MMP-7 and Osteopontin-b
by: Stacey Van Pelt (15129557)
Published: (2025)

Supplementary Figure 6 from Tunneling CARs: Increasing CAR T-Cell Tumor Infiltration through the Overexpression of MMP-7 and Osteopontin-b
by: Stacey Van Pelt (15129557)
Published: (2025)

Figure S4 from Evaluation of Proton Minibeam Radiotherapy on Antitumor Immune Responses in a Rat Model of Glioblastoma
by: Lorea Iturri (22547185)
Published: (2025)

Supplementary Table 1 from Somatic Mutations in HLA Class Genes and Antigen-Presenting Molecules in Malignant Glioma
by: Sara C. Schulte (21644540)
Published: (2025)

Supplementary Table 2 from Somatic Mutations in HLA Class Genes and Antigen-Presenting Molecules in Malignant Glioma
by: Sara C. Schulte (21644540)
Published: (2025)

Supplementary Table 3 from Somatic Mutations in HLA Class Genes and Antigen-Presenting Molecules in Malignant Glioma
by: Sara C. Schulte (21644540)
Published: (2025)

Data Sheet 2_Comprehensive analysis of palmitoylation-related proteins for prognostic risk evaluation and tumor immune microenvironment assessment in glioma.docx
by: Jihao Xue (20893016)
Published: (2025)

Data Sheet 1_Comprehensive analysis of palmitoylation-related proteins for prognostic risk evaluation and tumor immune microenvironment assessment in glioma.docx
by: Jihao Xue (20893016)
Published: (2025)

Data Sheet 1_Sialylation-related gene signature predict prognosis and immunotherapy efficacy in low- and high-grade glioma: a PCA-based stratification study.pdf
by: Guidong Zhu (587519)
Published: (2025)

Table 1_Prognostic value of metal-based ferroptosis and cuproptosis genes and score in lower grade gliomas.xlsx
by: Umair Ali Khan Saddozai (11000166)
Published: (2025)

Table 3_Prognostic value of metal-based ferroptosis and cuproptosis genes and score in lower grade gliomas.xlsx
by: Umair Ali Khan Saddozai (11000166)
Published: (2025)

Table 2_Prognostic value of metal-based ferroptosis and cuproptosis genes and score in lower grade gliomas.xlsx
by: Umair Ali Khan Saddozai (11000166)
Published: (2025)

Table 4_Prognostic value of metal-based ferroptosis and cuproptosis genes and score in lower grade gliomas.xlsx
by: Umair Ali Khan Saddozai (11000166)
Published: (2025)

Data Sheet 1_Prognostic value of metal-based ferroptosis and cuproptosis genes and score in lower grade gliomas.pdf
by: Umair Ali Khan Saddozai (11000166)
Published: (2025)

Supplementary Figures from Distinct Cell Adhesion Signature Defines Glioblastoma Myeloid-Derived Suppressor Cell Subsets
by: Defne Bayik (14961098)
Published: (2025)

Table S2 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors
by: Joseph Toker (15399882)
Published: (2025)

Table S3 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors
by: Joseph Toker (15399882)
Published: (2025)

Table S4 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors
by: Joseph Toker (15399882)
Published: (2025)

Table S5 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors
by: Joseph Toker (15399882)
Published: (2025)

Table S6 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors
by: Joseph Toker (15399882)
Published: (2025)

Table S7 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors
by: Joseph Toker (15399882)
Published: (2025)